Literature DB >> 26449551

Effects of continuous positive airway pressure treatment on coronary vasoreactivity measured by (82)Rb cardiac PET/CT in obstructive sleep apnea patients.

Vincent Dunet1,2, Vincianne Rey-Bataillard3, Gilles Allenbach1, Nicolas Beysard3, Alban Lovis3, John O Prior4, Raphael Heinzer3.   

Abstract

PURPOSE: Obstructive sleep apnea syndrome (OSA) increases the risk of cardiovascular disease. We aimed at evaluating the effect of continuous positive airway pressure (CPAP) treatment on coronary endothelium-dependent vasoreactivity in OSA patients by quantifying myocardial blood flow (MBF) response to cold pressure testing (CPT).
METHODS: In the morning after polysomnography (PSG), all participants underwent a dynamic (82)Rb cardiac positron emitting tomography/computed tomography (PET/CT) scan at rest, during CPT and adenosine stress. PSG and PET/CT were repeated at least 6 weeks after initiating CPAP treatment. OSA patients were compared to controls and according to response to CPAP. Patients' characteristics and PSG parameters were used to determine predictors of CPT-MBF.
RESULTS: Thirty-two untreated OSA patients (age 58 ± 13 years, 27 men) and 9 controls (age 62 ± 5 years, 4 men) were enrolled. At baseline, compared to controls (apnea-hypopnea index (AHI) = 5.3 ± 2.6/h), untreated OSA patients (AHI = 48.6 ± 19.7/h) tend to have a lower CPT-MBF (1.1 ± 0.2 mL/min/g vs. 1.3 ± 0.4 mL/min/g, p = 0.09). After initiating CPAP, CPT-MBF was not different between well-treated patients (AHI <10/h) and controls (1.3 ± 0.3 mL/min/g vs. 1.3 ± 0.4 mL/min/g, p = 0.83), but it was lower for insufficiently treated patients (AHI ≥10/h) (0.9 ± 0.2 mL/min/g vs. 1.3 ± 0.4 mL/min/g, p = 0.0045). CPT-MBF was also higher in well-treated than in insufficiently treated patients (1.3 ± 0.3 mL/min/g vs. 0.9 ± 0.2 mL/min/g, p = 0.001). Mean nocturnal oxygen saturation (β = -0.55, p = 0.02) and BMI (β = -0.58, p = 0.02) were independent predictors of CPT-MBF in OSA patients.
CONCLUSIONS: Coronary endothelial vasoreactivity is impaired in insufficiently treated OSA patients compared to well-treated patients and controls, confirming the need for CPAP optimization.

Entities:  

Keywords:  Continuous positive airway pressure; Endothelial function; Obstructive sleep apnea; PET

Mesh:

Substances:

Year:  2015        PMID: 26449551     DOI: 10.1007/s11325-015-1272-1

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  29 in total

1.  Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.

Authors:  Virginia A Imadojemu; Kevin Gleeson; Sadeq A Quraishi; Allen R Kunselman; Lawrence I Sinoway; Urs A Leuenberger
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

Review 2.  Obstructive sleep apnea: an emerging risk factor for atherosclerosis.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2011-08       Impact factor: 9.410

3.  Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea.

Authors:  Sanja Jelic; Margherita Padeletti; Steven M Kawut; Christopher Higgins; Stephen M Canfield; Duygu Onat; Paolo C Colombo; Robert C Basner; Phillip Factor; Thierry H LeJemtel
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690

4.  Chronic intermittent hypoxia causes endothelial dysfunction in a mouse model of diet-induced obesity.

Authors:  Mohammad Badran; Saeid Golbidi; Angela Devlin; Najib Ayas; Ismail Laher
Journal:  Sleep Med       Date:  2014-02-19       Impact factor: 3.492

5.  Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy.

Authors:  Nikolaus J Büchner; Ivo Quack; Magdalena Woznowski; Constanze Stähle; Ulrich Wenzel; Lars C Rump
Journal:  Respiration       Date:  2011-02-09       Impact factor: 3.580

6.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

7.  The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea.

Authors:  Selma Firat Guven; Mustafa Hamidullah Turkkani; Bulent Ciftci; Tansu Ulukavak Ciftci; Yurdanur Erdogan
Journal:  Sleep Breath       Date:  2011-02-18       Impact factor: 2.816

8.  Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation.

Authors:  J L Lattimore; I Wilcox; M Skilton; M Langenfeld; D S Celermajer
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

Review 9.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

Review 10.  Oral appliances for snoring and obstructive sleep apnea: a review.

Authors:  Kathleen A Ferguson; Rosalind Cartwright; Robert Rogers; Wolfgang Schmidt-Nowara
Journal:  Sleep       Date:  2006-02       Impact factor: 5.849

View more
  1 in total

Review 1.  Coagulation and Fibrinolysis in Obstructive Sleep Apnoea.

Authors:  Andras Bikov; Martina Meszaros; Esther Irene Schwarz
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.